Outcomes research will get a boost from an Optum / Mayo Clinic collaboration
Optum Labs will run analytics on millions of claims and clinical records to find improved outcomes
“Our strategic research alliance with Optum Labs will leverage what we believe to be the largest combined source of clinical and claims information, providing a more comprehensive picture of patients’ diagnoses, progression of diseases, comparative treatments and outcomes,” said John Noseworthy, MD, CEO of Mayo Clinic (Rochester, MN), in announcing the undertaking. According to press reports, Mayo will bring over five million clinical records, going back 15 years, while Optum (a healthcare analytics part of the insurer UnitedHealth Group, based in Minneapolis) will bring claims records of 100 million patients spanning 20 years. Together, using the latest “big data” analytics techniques, the partners will attempt to gain insights into optimal treatments, variations in care and comparative effectiveness of therapies. Unlike the outcomes research being developed at HHS, however, Optum Labs will be free to look at cost effectiveness of therapies as well. The collaboration is based in Cambridge, MA, and is open to participation from academic institutions, life sciences companies, commercial and government payers.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
